Raise Your Voice for Meningococcal Disease Vaccination MKT19193.

20
Raise Your Voice for Meningococcal Disease Vaccination MKT19193

Transcript of Raise Your Voice for Meningococcal Disease Vaccination MKT19193.

Raise Your Voice for Meningococcal Disease Vaccination

MKT19193

Slide 2

Welcome

[NAME]

[TITLE]

[National Association of School Nurses Affiliate]

Slide 3

Clinical Overview: Meningococcal Disease

• Infection caused by the bacterium Neisseria meningitidis1

—Serotypes A, B, C, Y, and W-135 cause majority of meningococcal disease cases worldwide2

—Leading cause of bacterial meningitis among US toddlers, children and adolescents

• Serotypes B, C, and Y most common in US2

• Meningococcal disease can cause meningitis (swelling of the brain or spinal cord) or meningococcemia (blood infection)3

• Vaccination is safe and effective and the best way to help prevent the disease among adolescents3

References:1. Centers for Disease Control and Prevention (CDC). Meningococcal disease – New England, 1993 – 1998. MMWR. 1999;48(29):629-633. 2. CDC. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds. 10th ed. Washington, D.C.: Public Health Foundation, 2008. 3. CDC. Meningococcal vaccines: what you need to know. http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-mening.pdf. Accessed April 7, 2010.

Slide 4

• Approximately 1000 to 2600 Americans get meningococcal disease annually1

— The disease rates peak at 15-19 years of age2

• When meningococcal disease occurs the consequences can be devastating1

— Fast progressing…can take a life in just a single day3

— Teens are up to 5 times more likely to die than other age groups2

— Among survivors, 1 in 5 will suffer permanent complications• Amputation, hearing loss, neurological damage, and organ failure1,4

• Early symptoms can resemble the flu, making diagnosis difficult— Symptoms include fever, headache, stiff neck, nausea and vomiting,

and rash5-6

Clinical Overview: Meningococcal Disease

References:1. CDC. Meningococcal vaccines: what you need to know. http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-mening.pdf. Accessed April 7, 2010. 2. Harrison LH, Pass MA, Mendelsohn AB, et al. Invasive meningococcal disease in adolescents and young adults. JAMA. 2001;286:695-699. 3. Erickson LJ, De Wals P, McMahon J, Heim S. Complications of meningococcal disease in college students. Clin Infect Dis. 2001;33:737-739. 4. National Meningitis Association. Overview. http://www.nmaus.org/meningitis. Accessed April 7, 2010. 5. Granoff DM, Harrison LH, Borrow R. Meningococcal vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 5th edition. Philadelphia, Pa: Elsevier Inc; 2008:399-435. 6. National Meningitis Association. Symptoms. http://www.nmaus.org/meningitis/symptoms.htm. Accessed April 7, 2010.

Slide 5

Clinical Overview: Meningococcal Disease

• Spread from person to person through close, personal contact and exchange of respiratory secretions1

• Common everyday activities can put adolescents at increased risk for infection; these activities or risks include:1-2

— Sharing drinking glasses and eating utensils

— Kissing

— Living in close quarters

— Smoking (or being exposed to smoke)

• Meningococcal disease can occur at any point during the year — Late-winter and early-spring are when most cases occur3

References:1. Granoff DM, Harrison LH, Borrow R. Meningococcal vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 5th edition. Philadelphia, Pa: Elsevier Inc; 2008:399-435. 2. National Meningitis Association. Who is at risk. http://www.nmaus.org/meningitis/who-is-at-risk.htm. April 7, 2010. 3. CDC. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds. 10th ed. Washington, D.C.: Public Health Foundation, 2008.

Slide 6

Clinical Overview: Meningococcal Disease

• Once diagnosed with meningococcal disease, early antibiotic treatment is critical1

—Even with treatment, meningococcal disease can kill an otherwise healthy young person1-2

• Close contacts should also receive preventive antibiotics1

—Family members, close friends

References:1. Rosenstein NE, et al. Meningococcal disease. N Engl J Med. 2001;344(18):1378. 2. Erickson LJ, De Wals P, McMahon J, Heim S. Complications of meningococcal disease in college students. Clin Infect Dis. 2001;33:737-739.

Slide 7

Vaccination – The Best Protection

• Vaccination continues to be the best way to prevent meningococcal disease—Helps protect against 4 of the 5 primary serotypes (A, C, Y, and W-

135)1

• Centers for Disease Control and Prevention (CDC) recommends routine vaccination for:2-3

—Adolescents 11-18 years of age—College freshmen living in dormitories—Children 2 through 10 years of age at increased risk—Anyone 2 through 10 years of age if elected by parent or health-care

provider

References:1. CDC. Meningococcal vaccines: what you need to know. http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-mening.pdf. Accessed April 7, 2010. 2. CDC. Notice to readers: revised recommendations of the ACIP to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine. MMWR. 2007;56(31):794-795. 3. CDC. Notice to readers: recommendation from the ACIP for use of quadrivalent meningococcal conjugate vaccine (MCV4) in children aged 2-10 years at increased risk for invasive meningococcal disease. MMWR. 2007;56(48):1265-1266.

Slide 8

Vaccination Rates Alarmingly Low

• In 2008, only 41.8% of teens 13-17 years of age received the recommended meningococcal vaccine1 —Far from the CDC’s goal of a 90% immunization rate2

• Florida has a 33.6% rate of meningococcal vaccination among adolescents 13-17 years of age

References:1. CDC. National Immunization Survey (NIS) adolescents/teens only: coverage with Individual vaccines. http://www.cdc.gov/vaccines/stats-surv/nisteen/tables/08/tab01_iap.xls. Accessed

April 7, 2010. 2. CDC. National, state, and local area vaccination coverage among adolescents aged 13-17 Years - United States, 2008. MMWR. 2009;58(36);997-1001.

Slide 9

Why Aren’t More Teens Getting Vaccinated?1-3

• Many parents and students still unaware of disease, vaccine

• Fewer health maintenance visits

• Missed immunization opportunities

• Lack of population-based immunization registries that include adolescents

• Low public awareness about adolescent immunization coverage, recommendations, and available vaccinations

• Misperceptions about vaccine safety

References:1. National Foundation for Infectious Diseases (NFID). Meningococcal vaccination: improving rates in adolescents and reducing racial, ethnic and socioeconomic disparities, 2008. http://stopmeningitis.nfidinitiatives.org/pdf/CTA.pdf. Accessed April 7, 2010. 2. Oster NV, et al. Barriers to adolescent immunization: a survey of family physicians and pediatricians. J Am Board Fam Pract. 2005;18(1):13. 3. Freed GL, Clark SJ, Butchart AT. Parental vaccine safety concerns in 2009. Pediatrics. 2010;10:654-659.

Slide 10

Vaccination Requirements in Elementary and Secondary Schools1-4

References:1. Immunization Action Coalition. Meningococcal state mandates for elementary and secondary schools. http://www.immunize.org/laws/menin_sec.asp. Accessed April 7, 2010. 2. New York State Department of Health. New York recommended childhood and adolescent immunization schedule. http://www.health.state.ny.us/publications/2378.pdf. Accessed April 7, 2010. 3. Indiana State Department of Health. 2010-2011 school year Indiana State Department of Health (ISDH) school immunization requirements quick reference guide. http://www.hse.k12.in.us/PDF/clinicalServices/Immunization%20Chart.pdf. Accessed April 7, 2010. 4. Michigan Department of Community Health. New communicable disease rules 2010-2011 school reporting year. http://www.swartzcreek.org/Pupil/SS_NewSchReqmnts1-10.pdf. Accessed April 7, 2010. 5. State of California Legislative Counsel. California Health and Safety Code. http://www.leginfo.ca.gov/cgi-bin/waisgate?WAISdocID=26994629975+0+0+0&WAISaction=retrieve. Accessed May 7, 2010.

States requiring vaccinationStates requiring education

Slide 11

School Nurses: Helping to Prevent Meningococcal Disease

• School nurses play an instrumental role in raising awareness about meningococcal disease and vaccination—Leading advocate in adolescent health —Direct reach to adolescents, parents, and families—Trusted source of health information

• Parents rely on school nurses for information surrounding the health and well-being of their children

Slide 12

• Become a “Voice” of Meningitis

• A public awareness campaign by the National Association of School Nurses (NASN) in collaboration with sanofi pasteur—Gives “voice” to meningitis through sharing stories of those

personally affected by the disease

• Parents

• Disease survivors

• School nurses

How You Can Help Support Educational Efforts in Florida

Slide 13

Voices of Meningitis Objectives

• Empower school nurses to further educate parents, teens—Parents rely on school nurses for health information

• Educate parents and teens about dangers of meningococcal disease, encourage them to seek vaccination

• Encourage dialog between parents, school nurses, and other health-care providers about meningococcal vaccination

Slide 14

Voices of Meningitis Challenge

• “Challenges” school nurses to implement meningococcal educational efforts

• Provides school nurses with resources and strategies

• Recognizes school nurses for their educational efforts—Highlights successes in raising awareness of

meningococcal disease and prevention

• Fosters sharing of ideas and strategies nationwide

Slide 15

Voices of Meningitis Challenge

• Challenge “Champions” to offer guidance and support

Great Plains

Mid-Atlantic

Midwest

New England

South

Southeast

Southwest

West

West RegionChampion: Cheryl Sampson;

[email protected]

Great Plains RegionChampion: Carol Tucker;

[email protected] and Polly Witt;

[email protected]

Midwest RegionChampion: Cindy Hiltz;

[email protected]

New England RegionChampion: Linda Twardowski;

[email protected]

Southwest RegionChampion: Linda Hummingbird;[email protected]

Mid-Atlantic RegionChampion: Beth Mattey;

[email protected]

Southeast RegionChampion: Jennifer Garrett;

[email protected] and

Kathleen Rose; [email protected]

South RegionChampion: Mary Glasscock;

[email protected], andShawn Smith;

[email protected]; and Michelle Keith;

[email protected]

Slide 16

Voices of Meningitis Challenge

• Implementation Guide—Provides ideas to initiate meningococcal disease awareness

programming within communities

• Educational materials —Posters—Brochure—Fact sheet—Report card sticker—Parent letters —Media materials—Educational videos

• Complimentary materials available on VoicesOfMeningitis.org

Slide 17

Voices of Meningitis Challenge

• Submit case studies of all awareness activities conducted— Case studies featured on the National Association of School Nurses

(NASN) Web site

— Serves as repository of ideas and strategies for school nurses nationwide

• Five case studies selected to be presented during the 2011 NASN Annual Conference

• Online submission form on NASN Web site

Slide 18

Tips to Use Online Resources

• Parent Mailings and Report Cards —Send a Voices of Meningitis brochure or letter home to your

students’ parents

• School Assembly—Discuss meningitis during a school assembly or pep rally—Show a Voices of Meningitis educational video

• Local Parent Teacher Association or Organization Partnership—Host a presentation during a regular scheduled meeting; distribute

materials

• Athletic Department Partnership—Involve athletic directors to distribute Voices of Meningitis fact sheets

with sports physical forms

Slide 19

• Happy (and Healthy) Graduation—Send information home with order forms for yearbooks, class

rings, cap and gown, etc.—Set up a table at college fairs

• Online vehicles—Distribute a note about meningitis vaccination via your school’s

parent listserv—Use the Voices of Meningitis widget to link your school’s Web site

with the campaign site

• Visit VoicesOfMeningitis.org

—Includes more information and ideas

Tips to Use Online Resources (con’t)

Slide 20

Questions?